Advertisement

Topics

Alembic gains FDA tentative approval for generic Latisse

15:34 EDT 15 Aug 2018 | Drug Store News

pharmacy/alembic-gains-fda-tentative-approval-for-generic-latisse/">

Alembic gets tentative approval from the FDA for a generic version of Allergan's Latisse ophthalmic solution. The product has a market value of approximately $63 million.

Read More

Original Article: Alembic gains FDA tentative approval for generic Latisse

NEXT ARTICLE

More From BioPortfolio on "Alembic gains FDA tentative approval for generic Latisse"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...